Use of a Polyethylene Glycol-Peptide Conjugate in a Competition Gel Shift Assay for Screening Potential Antagonists of HIV-1 Tat Protein Binding to TAR RNA

Jihong Wang, Shaei Yun Huang, Indrani Choudhury, Michael J Leibowitz, Stanley Stein

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Interference of binding of Tat protein to TAR RNA in HIV-1-infected cells may be a useful therapeutic strategy for AIDS. An electrophoretic assay to screen potential low-molecular-weight (<2 kDa) Tat antagonists has been established. A radiolabeled TAR RNA fragment (ΔTAR) is retarded in mobility when bound by a Tat peptide-polyethylene glycol conjugate (Tat-PEG), which is used in place of the Tat protein. The assay determines the ability of a potential antagonist to compete with Tat-PEG for binding to ΔTAR, as measured by interference with the gel shift of ΔTAR. To discriminate between specific and nonspecific interactions, the assay is done in the absence or the presence of a 250-fold molar excess of tRNA.

Original languageEnglish (US)
Pages (from-to)238-242
Number of pages5
JournalAnalytical Biochemistry
Volume232
Issue number2
DOIs
StatePublished - Dec 10 1995
Externally publishedYes

Fingerprint

Human Immunodeficiency Virus tat Gene Products
tat Gene Products
Protein Binding
HIV-1
Assays
Screening
Gels
RNA
Peptides
Transfer RNA
Carrier Proteins
Acquired Immunodeficiency Syndrome
Molecular Weight
Molecular weight
Therapeutics

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology
  • Biophysics
  • Biochemistry

Cite this

Use of a Polyethylene Glycol-Peptide Conjugate in a Competition Gel Shift Assay for Screening Potential Antagonists of HIV-1 Tat Protein Binding to TAR RNA. / Wang, Jihong; Huang, Shaei Yun; Choudhury, Indrani; Leibowitz, Michael J; Stein, Stanley.

In: Analytical Biochemistry, Vol. 232, No. 2, 10.12.1995, p. 238-242.

Research output: Contribution to journalArticle

@article{de2dba769aa2447b9d7898a65b5674b8,
title = "Use of a Polyethylene Glycol-Peptide Conjugate in a Competition Gel Shift Assay for Screening Potential Antagonists of HIV-1 Tat Protein Binding to TAR RNA",
abstract = "Interference of binding of Tat protein to TAR RNA in HIV-1-infected cells may be a useful therapeutic strategy for AIDS. An electrophoretic assay to screen potential low-molecular-weight (<2 kDa) Tat antagonists has been established. A radiolabeled TAR RNA fragment (ΔTAR) is retarded in mobility when bound by a Tat peptide-polyethylene glycol conjugate (Tat-PEG), which is used in place of the Tat protein. The assay determines the ability of a potential antagonist to compete with Tat-PEG for binding to ΔTAR, as measured by interference with the gel shift of ΔTAR. To discriminate between specific and nonspecific interactions, the assay is done in the absence or the presence of a 250-fold molar excess of tRNA.",
author = "Jihong Wang and Huang, {Shaei Yun} and Indrani Choudhury and Leibowitz, {Michael J} and Stanley Stein",
year = "1995",
month = "12",
day = "10",
doi = "10.1006/abio.1995.0013",
language = "English (US)",
volume = "232",
pages = "238--242",
journal = "Analytical Biochemistry",
issn = "0003-2697",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Use of a Polyethylene Glycol-Peptide Conjugate in a Competition Gel Shift Assay for Screening Potential Antagonists of HIV-1 Tat Protein Binding to TAR RNA

AU - Wang, Jihong

AU - Huang, Shaei Yun

AU - Choudhury, Indrani

AU - Leibowitz, Michael J

AU - Stein, Stanley

PY - 1995/12/10

Y1 - 1995/12/10

N2 - Interference of binding of Tat protein to TAR RNA in HIV-1-infected cells may be a useful therapeutic strategy for AIDS. An electrophoretic assay to screen potential low-molecular-weight (<2 kDa) Tat antagonists has been established. A radiolabeled TAR RNA fragment (ΔTAR) is retarded in mobility when bound by a Tat peptide-polyethylene glycol conjugate (Tat-PEG), which is used in place of the Tat protein. The assay determines the ability of a potential antagonist to compete with Tat-PEG for binding to ΔTAR, as measured by interference with the gel shift of ΔTAR. To discriminate between specific and nonspecific interactions, the assay is done in the absence or the presence of a 250-fold molar excess of tRNA.

AB - Interference of binding of Tat protein to TAR RNA in HIV-1-infected cells may be a useful therapeutic strategy for AIDS. An electrophoretic assay to screen potential low-molecular-weight (<2 kDa) Tat antagonists has been established. A radiolabeled TAR RNA fragment (ΔTAR) is retarded in mobility when bound by a Tat peptide-polyethylene glycol conjugate (Tat-PEG), which is used in place of the Tat protein. The assay determines the ability of a potential antagonist to compete with Tat-PEG for binding to ΔTAR, as measured by interference with the gel shift of ΔTAR. To discriminate between specific and nonspecific interactions, the assay is done in the absence or the presence of a 250-fold molar excess of tRNA.

UR - http://www.scopus.com/inward/record.url?scp=0029566871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029566871&partnerID=8YFLogxK

U2 - 10.1006/abio.1995.0013

DO - 10.1006/abio.1995.0013

M3 - Article

C2 - 8747481

AN - SCOPUS:0029566871

VL - 232

SP - 238

EP - 242

JO - Analytical Biochemistry

JF - Analytical Biochemistry

SN - 0003-2697

IS - 2

ER -